x

Search for a networks

* (*) mandatory field

Phase 3 Prospective, Randomized, Blinded, and Controlled Investigation of HepaSphere/QuadraSphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Carcinoma

  • Type of network : Multinational clinical trials
  • Geographic coverage : Global
  • Funding body(ies) : -
  • Sponsor : MERIT MEDICAL SYSTEMS, INC.
  • Website
  • Coordinator of multinational clinical trial

  • INFORMATION NOT PROVIDED
  • Merit Medical Systems, Inc.
  • 1600 West Merit Parkway
  • UT84095 SOUTH JORDAN
  • UNITED STATES
  • More information
  • Phone  : 001 801 253 1600
  • Fax  : -
  • Website
Last update: March 2018

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.